HHS Urges More Transparency On 340B Drug Prices
The U.S. Department of Health and Human Services on Tuesday called for increased transparency on the 340B Drug Discount Program's prices and claims, as well as clearer rules about providers' relationships...To view the full article, register now.
Already a subscriber? Click here to view full article